Company Overview: Clients include Pharmaceutical and Biotechnology. Regulatory and Clinical Research Organizations. Focus is GxP Consulting, Inspection Readiness and Process Improvement for Phase 3 Global Clinical Trials utilizing the Bioresearch Monitoring Program (BIMO)
Remote: (2019-present) Altimmune, Bioserenity, Aimmune, and Amylx
Clients: Daiichi Sankyo, Intercept, La Jolla Pharmaceuticals, and InClin, Inc. (Rare Disease)
Daiichi Sankyo (2015 - 2018): GCP auditor for phase III studies: Performs internal and external inspection readiness audits, to assure compliance with legal contracts, quality agreements, policies, procedures, global GCP regulations and guidelines
Intercept Pharmaceuticals (2015-2018): GCP Quality Assurance Consultant for Inspection Readiness
La Jolla Pharmaceutical Company (2015 2017): GCP Quality Assurance Consultant for Inspection Readiness
InClin, Inc (2013-2015): Quality Assurance Inspection Readiness consultant for EMA and FDA audits
Clients include Pharmaceutical and Biotechnology. Regulatory and Clinical Research Organizations. Focus is GxP Consulting, Inspection Readiness and Process Improvement for Phase 3 Global Clinical Trials utilizing the Bioresearch Monitoring Program (BIMO)
Clinical Program Manager
UNIVERSITY OF CALIFORNIA, San Diego
01.2012 - 01.2014
Company Overview: Department of Neurosciences
Provided leadership and direction for the ADCS Clinical Monitoring group which monitored multiple Phase II-III Alzheimer's Disease research trials at over 70 research sites throughout the United States, Canada, and Australia
Department of Neurosciences
Consultant
BERG PHARMA
01.2011 - 01.2013
Company Overview: (Oncology)
Provided Project, Program, Safety Committee and Financial Management services for this biotech company during a Phase I Pancreatic Oncology Trial. Monitored 2 clinical trial sites for GXP compliance.
(Oncology)
Consultant
NANOGEN
01.2011 - 01.2013
Company Overview: (Medical Diagnostics (Cardiovascular Device))
Advised key decision makers on process improvement.
High level presentations included financial analysis, case studies and process strategies.
Implemented process improvement and training in emergency departments.
Reported all key data points for clinical trial.
(Medical Diagnostics (Cardiovascular Device))
Consultant
MEMGEN
01.2011 - 01.2012
Monitored a Phase I trial at University of California, San Diego Cancer Center for compliance, GXP and Safety.
Clinical Operations Manager-Global
PFIZER
01.2006 - 01.2011
Managed multiple domestic and international clinical trial budgets.
Directed performance management of 14 Regional Site Managers.
Interviewed, hired and trained all direct reports.
Worked on the Torcetrapib/Atorvastatin Cardiovascular trials from study start-up through close out of all sites. Managed all legal issues through Pfizer.
Made strategic and tactical decisions for monitoring/study management activities.
Provided site and clinical investigator selection information to the therapeutic area project specialists.
Managed and coordinated operational aspects of clinical trial support within and across therapeutic groups.
Responsibilities included submitting high quality data and ensuring monitoring standards were in compliance with ICH/GXP and Pfizer SOP requirements.
Provided leadership to promote harmonization for standard working practices with a focus on increasing efficiencies.
Lead on the Infectious Disease audit team.
Worked primarily on Oncology, CNS, Cardiology, and HIV studies.
Clinical Research Site Manager
PFIZER
01.2006 - 01.2011
Monitored Phase I-IV Cardiovascular Trials.
Acted as Lead Clinical Research Site Manager for two protocols to include protocol training, process training and data distribution and collection. Met all deadlines given by project team.
Evaluated the monitoring plan throughout the conduct of a clinical study and revised as needed.
Managed data discrepancies for the entire study and coordinated the clinical monitoring activities to ensure that these discrepancies are resolved in the established timeframe for resolution.
Managed current product inventory throughout clinical study (retention samples for QA; laboratory studies product; clinical study product). Revises the clinical product inventory needs as indicated and communicates the revision to the Clinical Project Team.
Monitored study sites using reduced source documentation tools and electronic data capture Utilized MS Project to manage various studies.
Clinical Research Associate II-International Studies
BIOMARIN
01.2002 - 01.2004
Company Overview: (Rare Disease)
Data Management for International Pediatric studies ranging from Phase II through Phase IV.
Managed a CRO who monitored sites in England, Italy, Germany, France, and Brazil.
Managed a budget for each country involved in this study.
Managed shipping and receiving of laboratory samples internationally.
Managed regulatory inventory for five different countries.
(Rare Disease)
Education
Bachelor of Science - Biological Sciences
Trinity College
Burlington, VT
06-1996
Master of Arts - Public Administration
University of San Francisco
San Francisco, CA
05-1993
Bachelor of Arts - Accounting And Finance
East Carolina University
Greenville, NC
06-1987
Skills
Technical review
Accomplishments
Consulted on 10 FDA and 8 EMA inspections. All were successful and moved to the next stage of development.
Timeline
Clinical Program Manager
UNIVERSITY OF CALIFORNIA, San Diego
01.2012 - 01.2014
Consultant
BERG PHARMA
01.2011 - 01.2013
Consultant
NANOGEN
01.2011 - 01.2013
Consultant
MEMGEN
01.2011 - 01.2012
Clinical Operations Manager-Global
PFIZER
01.2006 - 01.2011
Clinical Research Site Manager
PFIZER
01.2006 - 01.2011
Inspection Readiness Consultant
Inspection Readiness Consulting, Inc.
03.2005 - Current
Clinical Research Associate II-International Studies
Senior Consultant at Office of the Assistant Secretary of Defense for Readiness (OASD(R) Force Readiness)Senior Consultant at Office of the Assistant Secretary of Defense for Readiness (OASD(R) Force Readiness)